{{Rsnum
|rsid=3181157
|Gene=CD9
|Chromosome=12
|position=6199357
|Orientation=plus
|GMAF=0.1777
|Gene_s=CD9
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 85.8 | 13.3 | 0.9
| HCB | 77.4 | 21.9 | 0.7
| JPT | 70.8 | 28.3 | 0.9
| YRI | 21.8 | 44.9 | 33.3
| ASW | 45.6 | 47.4 | 7.0
| CHB | 77.4 | 21.9 | 0.7
| CHD | 78.9 | 20.2 | 0.9
| GIH | 76.2 | 23.8 | 0.0
| LWK | 35.5 | 50.0 | 14.5
| MEX | 82.8 | 15.5 | 1.7
| MKK | 46.2 | 44.9 | 9.0
| TSI | 87.3 | 10.8 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23776197
  |Trait=Paclitaxel-induced neuropathy
  |Title=Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy.
  |RiskAllele=A
  |Pval=4E-6
  |OR=3.22
  |ORtxt=[1.96-5.29]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}